MW-150 dihydrochloride dihydrate is primarily used in research and development within the pharmaceutical industry. It is investigated for its potential as a therapeutic agent, particularly in the treatment of neurological disorders. The compound has shown promise in preclinical studies for its ability to modulate specific biological pathways, making it a candidate for further study in conditions such as Alzheimer's disease or other neurodegenerative illnesses. Researchers utilize it to explore its efficacy, safety, and mechanism of action in cellular and animal models. Its application is focused on advancing understanding and developing novel treatments for complex diseases.